Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuwei muxiang is a traditional Tibetan medicine (Minority medicine) compound preparation composed of six herbal ingredients[4][6]. It is used for the treatment of gastric ulcer, chronic non-atrophic gastritis, and has shown potential effects in animal and cell models against colorectal cancer[2][3][5]. The main reported pharmacological actions include anti-inflammatory, antioxidant, and potential antitumor effects, mediated through regulation of the PI3K-AKT signaling pathway, modulation of immune infiltration microenvironment, inhibition of oxidative stress, and possible influence on proteins associated with cancer development (e.g., Amy2, Furin)[2][3][5]. Key active components identified include protopine, piperine, eugenol, methyl gallate, gallic acid, and costunolide[2]. The formulation is described as a light yellow to yellow powder with a fragrant smell[4]. According to available data, the herbal ingredients typically include costus root, gardenia, pomegranate, wolfsbane, cardamom, and piper longit[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liuwei muxiang.